The pharmacological inhibition of ERAP1 in the CT26 CRC mouse model using ERAAP (ERAP1 homolog in mice) inhibitor leucinthiol and ERAAP siRNA correlated with tumor regression [33,34]. The gene discussed is ERAP1; the disease is neoplasm.